The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic

Abstract Background We investigated the relevance of various imaging markers for the clinical trajectory of cerebral amyloid angiopathy (CAA) patients in a memory clinic. Methods A total of 226 patients with probable CAA were included in this study with a mean follow-up period of 3.5 ± 2.7 years. Al...

Full description

Bibliographic Details
Main Authors: Hyemin Jang, Min Young Chun, Hee Jin Kim, Duk L. Na, Sang Won Seo
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13195-023-01161-5
_version_ 1797952640504561664
author Hyemin Jang
Min Young Chun
Hee Jin Kim
Duk L. Na
Sang Won Seo
author_facet Hyemin Jang
Min Young Chun
Hee Jin Kim
Duk L. Na
Sang Won Seo
author_sort Hyemin Jang
collection DOAJ
description Abstract Background We investigated the relevance of various imaging markers for the clinical trajectory of cerebral amyloid angiopathy (CAA) patients in a memory clinic. Methods A total of 226 patients with probable CAA were included in this study with a mean follow-up period of 3.5 ± 2.7 years. Although all had more than one follow-up visit, 173 underwent follow-up Mini-Mental Status Examination (MMSE) and Clinical Dementia Rating Sum of Boxes (CDR-SB) ranging from 2 to 15 time points. Among 226, 122 patients underwent amyloid-β (Aβ) PET imaging. The prevalence of intracerebral hemorrhage (ICH) and its imaging predictors was investigated. The effects of CAA imaging markers and Aβ PET positivity on longitudinal cognition based on the MMSE and CDR-SB were evaluated using mixed effects models. Results During the follow-up, 10 (4.4%) patients developed ICH: cortical superficial siderosis (cSS; hazard ratio [HR], 6.45) and previous lobar ICH (HR, 4.9), but lobar cerebral microbleeds (CMBs) were not predictors of ICH development. The presence of CMIs (p = 0.045) and Aβ positivity (p = 0.002) were associated with worse MMSE trajectory in CAA patients. Regarding CDR-SB trajectory, only Aβ positivity was marginally associated with worse longitudinal change (p = 0.050). Conclusion The results of the present study indicated that various imaging markers in CAA patients have different clinical relevance and predictive values for further clinical courses.
first_indexed 2024-04-10T22:49:37Z
format Article
id doaj.art-a555f68e01a443fb93ec9e443fbb2293
institution Directory Open Access Journal
issn 1758-9193
language English
last_indexed 2024-04-10T22:49:37Z
publishDate 2023-01-01
publisher BMC
record_format Article
series Alzheimer’s Research & Therapy
spelling doaj.art-a555f68e01a443fb93ec9e443fbb22932023-01-15T12:06:12ZengBMCAlzheimer’s Research & Therapy1758-91932023-01-011511910.1186/s13195-023-01161-5The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinicHyemin Jang0Min Young Chun1Hee Jin Kim2Duk L. Na3Sang Won Seo4Samsung Alzheimer’s Convergence Research Center, Samsung Medical CenterDepartments of Neurology, Samsung Medical Center, Sungkyunkwan University School of MedicineDepartments of Neurology, Samsung Medical Center, Sungkyunkwan University School of MedicineDepartments of Neurology, Samsung Medical Center, Sungkyunkwan University School of MedicineSamsung Alzheimer’s Convergence Research Center, Samsung Medical CenterAbstract Background We investigated the relevance of various imaging markers for the clinical trajectory of cerebral amyloid angiopathy (CAA) patients in a memory clinic. Methods A total of 226 patients with probable CAA were included in this study with a mean follow-up period of 3.5 ± 2.7 years. Although all had more than one follow-up visit, 173 underwent follow-up Mini-Mental Status Examination (MMSE) and Clinical Dementia Rating Sum of Boxes (CDR-SB) ranging from 2 to 15 time points. Among 226, 122 patients underwent amyloid-β (Aβ) PET imaging. The prevalence of intracerebral hemorrhage (ICH) and its imaging predictors was investigated. The effects of CAA imaging markers and Aβ PET positivity on longitudinal cognition based on the MMSE and CDR-SB were evaluated using mixed effects models. Results During the follow-up, 10 (4.4%) patients developed ICH: cortical superficial siderosis (cSS; hazard ratio [HR], 6.45) and previous lobar ICH (HR, 4.9), but lobar cerebral microbleeds (CMBs) were not predictors of ICH development. The presence of CMIs (p = 0.045) and Aβ positivity (p = 0.002) were associated with worse MMSE trajectory in CAA patients. Regarding CDR-SB trajectory, only Aβ positivity was marginally associated with worse longitudinal change (p = 0.050). Conclusion The results of the present study indicated that various imaging markers in CAA patients have different clinical relevance and predictive values for further clinical courses.https://doi.org/10.1186/s13195-023-01161-5Cerebral amyloid angiopathyPrognosisCognitionAmyloid βMicrobleedCortical superficial siderosis
spellingShingle Hyemin Jang
Min Young Chun
Hee Jin Kim
Duk L. Na
Sang Won Seo
The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic
Alzheimer’s Research & Therapy
Cerebral amyloid angiopathy
Prognosis
Cognition
Amyloid β
Microbleed
Cortical superficial siderosis
title The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic
title_full The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic
title_fullStr The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic
title_full_unstemmed The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic
title_short The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic
title_sort effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy a longitudinal study in a memory clinic
topic Cerebral amyloid angiopathy
Prognosis
Cognition
Amyloid β
Microbleed
Cortical superficial siderosis
url https://doi.org/10.1186/s13195-023-01161-5
work_keys_str_mv AT hyeminjang theeffectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT minyoungchun theeffectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT heejinkim theeffectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT duklna theeffectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT sangwonseo theeffectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT hyeminjang effectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT minyoungchun effectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT heejinkim effectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT duklna effectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic
AT sangwonseo effectsofimagingmarkersonclinicaltrajectoryincerebralamyloidangiopathyalongitudinalstudyinamemoryclinic